Idera Expands Management Team with Three Key Hires

By: via Benzinga
dera Pharmaceuticals (NASDAQ: IDRA), a clinical stage biopharmaceutical company developing novel therapeutics for orphan ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.